Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

CARSON TAHOE REGIONAL HEALTHCARE

NPI: 1730739129 · CARSON CITY, NV 89701 · Urgent Care Clinic/Center · NPI assigned 09/17/2019

$791K
Total Medicaid Paid
32,776
Total Claims
29,394
Beneficiaries
30
Codes Billed
2022-06
First Month
2024-12
Last Month

Provider Details

Authorized OfficialKUCERA, KATIE (CHIEF FINANCIAL OFFICER)
Parent OrganizationCARSON TAHOE REGIONAL HEALTHCARE
NPI Enumeration Date09/17/2019

Related Entities

Other providers sharing the same authorized official: KUCERA, KATIE

ProviderCityStateTotal Paid
CARSON TAHOE REGIONAL HEALTHCARE CARSON CITY NV $23.78M
CARSON TAHOE REGIONAL HEALTHCARE CARSON CITY NV $440K
CARSON TAHOE REGIONAL HEALTHCARE CARSON CITY NV $254K
CARSON TAHOE REGIONAL HEALTHCARE DAYTON NV $191K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2022 7,892 $158K
2023 13,102 $310K
2024 11,782 $322K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 10,483 9,203 $360K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 9,621 8,581 $238K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 1,806 1,619 $97K
71046 Radiologic examination, chest; 2 views 589 552 $42K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 501 479 $22K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 387 355 $10K
73610 59 55 $6K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 205 185 $5K
73110 39 37 $3K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 93 86 $2K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 82 70 $2K
73630 49 43 $2K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 82 70 $2K
29125 95 89 $694.64
87807 474 436 $691.66
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1,434 1,322 $320.06
87186 139 129 $112.86
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 406 365 $96.85
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 2,216 2,065 $71.87
87086 Culture, bacterial; quantitative colony count, urine 801 731 $20.43
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1,207 1,111 $8.18
81002 1,197 1,093 $1.75
J7510 Prednisolone oral, per 5 mg 72 61 $0.00
81025 309 275 $0.00
J1885 Injection, ketorolac tromethamine, per 15 mg 129 117 $0.00
J1100 Injection, dexamethasone sodium phosphate, 1 mg 161 133 $0.00
J0696 Injection, ceftriaxone sodium, per 250 mg 33 27 $0.00
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 32 31 $0.00
87077 62 61 $0.00
0352U 13 13 $0.00